Abstract 104P
Background
Gastrointestinal stromal tumor (GIST) is a rare type of soft tissue sarcoma that most commonly arises from gastric mesenchymal cells. This study represents the first-ever form of GIST registry or database in Lebanon. The aim of this study is to describe and compare the Lebanese cohort of GIST cases and their management to the findings of international reports and gold standards.
Methods
This is a retrospective medical chart review of GIST cases diagnosed at the American University of Beirut Medical Center and Hammoud Hospital University Medical Center between the years 1996 and 2017.
Results
The database includes 106 GIST cases with a median age of 63.5 years (24-90). The median tumor size is 6 cm (0.3-21) with the most common presenting symptoms being abdominal pain and anemia. Endoscopy is the most commonly utilized diagnostic modality (49%) with confirmatory biopsy done in 42% of the cases. The most common tumor location is gastric (56.7%) followed by the small intestine (32.7%) and colon (7.7%). Noteworthy, the most common tumor size in females is between 5-10cm while in males is between 2-5cm. The most common cell type identified is the spindle cell (65.7%). CD 117 and CD 34 are positive in 91% and 78% of the cases, respectively. Only 14.7% of the cases received neoadjuvant therapy in the form of chemo- or targeted therapy while 31% received adjuvant therapy in either form. For cases that received adjuvant imatinib or sunitinib, the median tumor size is 8.8cm (4-20cm). Most patients (91%) underwent surgery, either by laparotomy (66%) or laparoscopy (34%). Of those, 97.7% had negative surgical margins. Recurrence occurred in 18.7% of cases with regional and distant recurrence occurring equally (35%) versus local recurrence (30%). The 3- and 5-year disease-free survival is 80% and 76% respectively.
Conclusions
Findings from this collaborative study add to the international epidemiology of GIST. It also shows that GIST features, as well as medical and surgical practices in this Lebanese cohort, conform with those reported from other populations.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
57P - V-set and immunoglobulin domain containing 1 (VSIG1): Gene vs protein expression in colorectal cancer tissue samples
Presenter: Simona Gurzu
Session: Poster viewing 02
58P - Clinicopathologic profile and outcomes of rectal cancer (RC) in the young (<50 years old): A single institution experience
Presenter: Fatma Amina Hussin Ibrahim
Session: Poster viewing 02
59P - Platelet-derived growth factor (PDGF)-CC serum as clinical outcome predictor after six cycles of chemotherapy in colorectal cancer at RSMH Palembang
Presenter: Erty Sundarita
Session: Poster viewing 02
60P - Predictors of survival in stage III colorectal cancer patients treated with surgery and adjuvant chemotherapy: A single institution observational study
Presenter: Keng Man Chiang
Session: Poster viewing 02
61P - Can total neoadjuvant therapy in locally advanced rectal cancer replace standard treatment protocol?
Presenter: Ankita Mallick
Session: Poster viewing 02
62P - Chief complaints and baseline clinicopathological features of patients with colorectal cancer in a tertiary hospital in Yogyakarta Indonesia
Presenter: Yasjudan Putra
Session: Poster viewing 02
63P - Tumor sidedness and clinicopathological features of colorectal cancer in Medical Oncology Department, Yangon General Hospital: A retrospective review
Presenter: Thiri Tun
Session: Poster viewing 02
64P - Clinical profile and treatment outcome of patients with non-metastatic colon cancer: A single institutional study from India
Presenter: Sandip Ganguly
Session: Poster viewing 02
65P - Comparison of survival and recurrence pattern in Thai early stage colorectal cancer patients by tumor sidedness
Presenter: Chanchai Charonpongsuntorn
Session: Poster viewing 02
77P - Long-term outcomes of indocyanine green fluorescence imaging-guided laparoscopic lymphadenectomy for gastric cancer: The FUGES-012 randomized clinical trial
Presenter: Qing Zhong
Session: Poster viewing 02